172@29@17@151!~!172@29@0@53!~!|news|tags|kiran-mazumdar-shaw.html|page-7|!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
kiran mazumdar shaw
Jump to
167 Results Found
  • Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr Apr 27, 2012 11:18 AM IST

    Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr

    Pharmaceutical company Biocon has reported better than expected topline as well as bottomline numbers in its fourth quarter of FY12. Its net profit fell 3% to Rs 98 crore in the January-March quarter of 2012 from Rs 101 crore in a year ago period.

  • Pfizer ending Insulin deal a big blow for Biocon; shrs tank Mar 13, 2012 10:30 AM IST

    Pfizer ending Insulin deal a big blow for Biocon; shrs tank

    Pfizer - Biocon alliance has called off due to individual priorities and in Shares of Biocon fell more than 8% on Tuesday morning after US pharma major Pfizer scrapped a deal to sell insulin products made by the Bangalore-based biotechnology company.

  • Biocon sees larger licensing income from pharma Jan 25, 2012 11:02 AM IST

    Biocon sees larger licensing income from pharma

    Biocon, India's top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing Director said on Wednesday.

  • Rupee depreciation: India needs steps in considered way Nov 24, 2011 04:36 PM IST

    Rupee depreciation: India needs steps in considered way

    In the wake of the depreciation of the Rupee against the US Dollar, India needs to implement measures in a considered and thoughtful way, Chairperson and Managing Director of Biocon Limited, Kiran Mazumdar Shaw said today.

  • Biocon Q2 net drops as energy costs, wages rise Oct 20, 2011 11:15 AM IST

    Biocon Q2 net drops as energy costs, wages rise

    Biocon Ltd, India top biotechnology company, reported a 4% drop in quarterly profit due to higher energy costs and rise in wages, but said strong demand from branded formulations offered opportunities for growth.

  • Govt seems to be doing sub-optimal job with tax money: Shaw Oct 14, 2011 11:46 AM IST

    Govt seems to be doing sub-optimal job with tax money: Shaw

    Europe's wealthy have asked to be taxed more, but a top Indian technocrat has put question marks over the ability of the government in India doing a good job with such funds if a law was passed in this regard.

  • Entrepreneurship lessons from Biocon's Kiran Mazumdar-Shaw Sep 24, 2011 04:25 PM IST

    Entrepreneurship lessons from Biocon's Kiran Mazumdar-Shaw

    India's largest listed biotechnology firm Biocon's chairperson and managing director Kiran Mazumdar-Shaw is one of India's most successful entrepreneurs.

  • Red tapism hurting biotechnology industry in India: Shaw Sep 21, 2011 06:30 PM IST

    Red tapism hurting biotechnology industry in India: Shaw

    Expressing concerns over the bureaucratic bottlenecks involved in conducting clinical research and trials in biotechnology sector in India, the industry experts today appealed to the regulatory authorities to stick to the "rule book" rather than "subjectivity".

  • Biocon to list Syngene in 18 months: Shaw Sep 20, 2011 05:52 PM IST

    Biocon to list Syngene in 18 months: Shaw

    Speaking to CNBC-TV18 in an exclusive chat, Kiran Mazumdar-Shaw, CMD of Biocon said they are looking to list the research and manufacturing arm of the company, Syngene, in 18 months time.

  • An opportunity to clean system of corruption: Biz leaders Aug 28, 2011 11:17 AM IST

    An opportunity to clean system of corruption: Biz leaders

    With the nation's focus on corruption as highlighted by Anna Hazare, business leaders see an opportunity for cleaning up the system by openness and abolition of red tape which generates corruption.

  • Listing research arm, new launches to lift margins: Biocon Jul 21, 2011 10:17 PM IST

    Listing research arm, new launches to lift margins: Biocon

    A steep fall in licensing income saw Biocon's net profit fall unexpectedly. Despite an 11% surge in net income, the company's net profit slipped 9% to Rs 70 crore.

  • Biocon Q1 net down 9% to Rs 70 crore, shares fall Jul 21, 2011 09:41 AM IST

    Biocon Q1 net down 9% to Rs 70 crore, shares fall

    Biotechnology company Biocon's consolidated net profit for the first quarter fell almost 9% from a year ago to Rs 70.05 crore, while net sales were up over 10% to Rs 441.68 crore.

  • Economics of innovation is not understood in India: Biocon Jun 18, 2011 03:17 PM IST

    Economics of innovation is not understood in India: Biocon

    Bio-tech queen Kiran Mazumdar-Shaw spills the beans on CNBC-TV18’s Forbes India Show about her past, present and future.

  • Pfizer partnership to give Biocon strong foothold in Europe Apr 28, 2011 11:00 PM IST

    Pfizer partnership to give Biocon strong foothold in Europe

    This quarter Biocon's net profit has risen 25% from the same period last year to 101 crore rupees, meeting analyst estimates and to keep this growth going, Biocon is shedding the fat, reports CNBC-TV18's Vineetha Athrey.

  • PM-India Inc meet: Key takeaways Mar 31, 2011 10:48 PM IST

    PM-India Inc meet: Key takeaways

    The trade and industry council chaired by the Prime Minister met in the capital today. The 23 member council discussed key economic policy issues. CNBC-TV18's Aakansha Sethi reports on the key takeaways from that meeting.

  • Biocon delivers stellar Q3 nos, plans to diversify biz Jan 20, 2011 09:20 PM IST

    Biocon delivers stellar Q3 nos, plans to diversify biz

    Biocon has had a spectacular third quarter. Its consolidated revenues for the period have surged 15%, and this has helped net profit jump 25%. CNBC-TV18's Vineetha Athrey finds out what Biocon's doing right, and what lies ahead.

  • Deal boost for Biocon Jan 04, 2011 09:35 AM IST

    Deal boost for Biocon

    The firm is looking at partnerships with global pharma majors as a ticket to hasten the launch of its biotech products

Sections